ADHD Cost Compare
Regional Guide — USA

ADHD Telehealth Prescriptions in 2026: What the Federal Extension Allows

Prepared by ADHD Cost CompareHow we source costsLast reviewed

Quick Summary

A DEA and HHS temporary rule lets DEA-registered practitioners prescribe Schedule II to V controlled substances after a video visit, with no prior in-person exam, from January 1 through December 31, 2026. It sets four conditions, leaves state law in place, and expires at the end of the year unless extended. This guide explains what that means for ADHD patients.

한국어 요약 보기

DEA와 HHS의 임시 규정은 2026년 1월 1일부터 12월 31일까지 DEA 등록 의료인이 대면 진료 없이 화상 진료 후 2~5군 통제약물을 처방할 수 있게 합니다. 네 가지 조건이 있고, 주법은 그대로 적용되며, 연장되지 않으면 연말에 종료됩니다. 이 글은 ADHD 환자에게 이것이 어떤 의미인지 설명합니다.

Right now, a clinician can prescribe an ADHD stimulant after a video visit without ever meeting you in person. That is allowed by a federal temporary rule that runs from January 1 through December 31, 2026. The rule has four conditions, does not override state law, and ends at the end of the year unless it is extended. If your care depends on remote prescribing, plan for what happens after that date.

What the Rule Says

Patient preparing for an online healthcare visit Source: Pexels

The DEA and HHS published the fourth temporary extension of the COVID-era telemedicine flexibilities on December 31, 2025. It lets DEA-registered practitioners prescribe Schedule II through V controlled substances through telemedicine without a prior in-person medical evaluation, effective January 1 through December 31, 2026 (Federal Register). The agencies describe the purpose as preventing a "telemedicine cliff," meaning the return of the restrictions that applied before the pandemic.

All four of these conditions must be met, according to the rule:

• The prescription is issued for a legitimate medical purpose by a practitioner acting in the usual course of professional practice. • It is issued after a communication over an interactive telecommunications system, which the rule ties to the Medicare definition in 42 CFR 410.78(a)(3). • The practitioner holds a DEA registration covering the drug class prescribed, or is exempt from registration. • The prescription follows the other requirements of 21 CFR part 1306.

That last condition is why a telehealth prescription still has to look like any other controlled-substance prescription.

What the Rule Does Not Do

Clinician speaking with a patient during a virtual appointment Source: Pexels

The rule is a federal floor, not a promise that a company will prescribe to you. A clinician can still decide that an in-person exam is needed, that a stimulant is not right for you, or that more evaluation must come first. State licensing and prescribing laws still apply, and we could not verify each state's current rules, so ask the clinician which state law governs your visit. Insurance plans and pharmacies can add their own requirements, for example prior authorization or limits on quantity.

The rule has an end date. The DEA and HHS issued it without prior notice and comment, citing good cause, and it states that DEA still intends to finalize permanent rules. A special registration framework for telemedicine was proposed in January 2025, and the extension document does not finalize it (Federal Register). So we cannot tell you what rules will apply on January 1, 2027, and nobody should promise you one.

Where This Sits in the Rest of the Rules

Patient writing questions before a telehealth appointment Source: Pexels

Two other final rules, one on buprenorphine and one on VA prescribers, were published in January 2025 and take effect on December 31, 2025. The extension is a separate authority, so a prescriber can use it even if a prescription could also fall under one of those rules. Neither of those two rules is aimed at ADHD stimulants.

For an adult with ADHD, the practical result is simple. Until December 31, 2026, a video visit can be enough for a prescriber to start or continue a stimulant, if the four conditions and your state's rules are met. After that date, the law reverts to whatever DEA has finalized or extended, and you should check the official source before relying on a company's marketing.

Questions to Ask Before You Book

Clinician reviewing follow-up notes after a remote visit Source: Pexels

Ask who will conduct the evaluation, what license they hold, and whether it is valid in your state. Ask whether the visit will be by video, and what the clinic does if the video connection fails. Ask how follow-ups work, how often they are needed, and how much each costs. Ask what the clinic plans to do after December 31, 2026 if the rule is not extended, including whether it would require an in-person visit. Ask whether your pharmacy and your plan will cover the medication, since a prescription is not the same as coverage.

Beware of any company that guarantees a prescription before an evaluation. A real clinical evaluation can end in a different treatment or a referral. See our telehealth diagnosis guide for what two companies publicly charge, and our medication cost guide for what drugs cost.

If You Rely on Remote Prescribing

Keep copies of your diagnosis report and your medication history so you can move to another clinician if you need to. Ask your clinician how far ahead to request each prescription, because a gap in supply can happen for reasons unrelated to the rule. If a drug is out of stock, our shortage guide covers what to do. Check the Federal Register or your clinician in December for any change.

Frequently Asked Questions

Does this rule allow phone-only visits for ADHD? The condition in the rule is an interactive telecommunications system as defined in 42 CFR 410.78(a)(3). Ask the clinician what format they use and whether audio-only is accepted, since we have not verified how that definition applies to every case.

Is the rule permanent? No. It runs through December 31, 2026.

Does it apply in Canada? No. It is a US rule for DEA-registered practitioners.

Sources

Federal Register, fourth temporary extension of COVID-19 telemedicine flexibilities


Rule details were read from the Federal Register text on October 24, 2026 and can change. This article is for information only and is not legal or medical advice.

Related Articles